. Asmar, New antiretroviral drugs in clinical use, 2006.

S. Choudhuri and C. D. Klaassen, Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters, ABCC (MRP), and ABCG2 (BCRP) efflux transporters, pp.231-259, 2006.
DOI : 10.1080/10915810600746023

M. B. De, C. Dhooge, and J. Philippe, Discordance of P-glycoprotein expression and function in acute leukemia, Adv.Exp.Med.Biol, vol.457, issue.13, pp.107-118, 1999.

F. German-fattal, R. Gimenez, S. R. Farinotti-faucette, T. C. Zhang, R. Moore et al., Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier, LeCluyse, M. Negishi, and H, pp.1525-1532, 2006.

. Wang, Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers, 2007.

V. , W. Ise, K. H. Sanders, W. R. Ulrich, and J. Beck, The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance, J.Antimicrob.Chemother. Biochem.Biophys.Res.Commun, vol.52, issue.17, pp.354-358345, 1995.

I. Licht, S. M. Pastan-hammer, M. S. Saag, M. Schechter, J. S. Montaner et al., Selection and maintenance of multidrug-resistant cells, Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel, pp.248-258827, 1998.

A. Hayashi, H. Suzuki, K. Itoh, M. Yamamoto, Y. Sugiyama-higgins et al., Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein1 in mouse embryo fibroblasts, Biochemical and Biophysical Research Communications, vol.310, issue.3, pp.824-82967, 1992.
DOI : 10.1016/j.bbrc.2003.09.086

Z. Hollo, L. Homolya, T. Hegedus, B. Sarkadi-homolya, L. et al., Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells, FEBS Letters, vol.30, issue.1-2, pp.99-104806, 1996.
DOI : 10.1016/0014-5793(96)00237-2

T. Imaoka, H. Kusuhara, M. Adachi, J. D. Schuetz, K. Takeuchi et al., Functional involvement of multidrug resistance-associated protein 4, 2007.

Q. Jiang, Y. Matsuzaki, K. Li, and J. Uitto, Transcriptional Regulation and Characterization of the Promoter Region of the Human ABCC6 Gene, Journal of Investigative Dermatology, vol.126, issue.2, pp.325-335, 2006.
DOI : 10.1038/sj.jid.5700065

. Clayette, ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages, Antivir.Ther, vol.9, pp.519-528, 2004.

P. A. Willson and . Edwards, Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid Xactivated receptor, and constitutive androstane receptor, 2002.

B. Killingley and A. Pozniak, The first once-daily single-tablet regimen for the treatment of HIV-infected patients, Drugs of Today, vol.43, issue.7, pp.427-442, 2007.
DOI : 10.1358/dot.2007.43.7.1086178

R. Krishna and L. D. Mayer, Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs, 2000.

G. Grosset, R. Lehne, O. Fauchet, and . Fardel, Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood, Life Sci, vol.68, pp.1323-1331, 2001.

C. G. Lee, M. M. Gottesman, C. O. Cardarelli, M. Ramachandra, K. T. Jeang et al., 1 Multidrug Transporter, Biochemistry, vol.37, issue.11, pp.3594-3601, 1998.
DOI : 10.1021/bi972709x

O. Legrand, G. Simonin, J. Y. Perrot, R. Zittoun, and J. P. Marie, Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients, Blood, vol.91, pp.4480-4488, 1998.

M. Levi and A. Pruvost, Abstr, 2006.

H. Sensitive, MS method for the simultaneous quantitative determination of Abacavir, Lamivudine and Tenofovir in human plasma

W. Loscher and H. Potschka, Blood-brain barrier active efflux transporters: ATP-binding cassette gene family, NeuroRX, vol.10, issue.Suppl 23, pp.86-98, 2005.
DOI : 10.1602/neurorx.2.1.86

T. Candussio, G. Giraldi, and . Decorti, Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC- PK1 cells, Eur.J.Pharmacol, vol.483, pp.19-28, 2004.

C. Schranz, K. Moecklinghoff, and . Arasteh, Predictors of treatment failure during highly active antiretroviral therapy (racing trial), Eur.J.Med.Res, vol.7, pp.341-346, 2002.

. Back, Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo, 2002.

S. P. Kurz, R. G. Cole, T. M. Deeley-ozben, L. L. Von-moltke, J. E. Marchand et al., Cloning and Characterization of the Murine and Rat mrp1 Promoter Regions Mechanisms and strategies to overcome multiple drug resistance in cancer Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line, Mol.Pharmacol. FEBS Lett. J.Pharm.Sci, vol.64, issue.90, pp.1259-1269, 2001.

J. Mccoll, J. J. Enejosa, A. K. Toole, and . Cheng, Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes--a 96-week analysis, 2006.

H. Negredo and . Benech, Specificity enhancement with LC-positive ESI-MS/MS for the measurement of nucleotides: application to the quantitative determination of carbovir triphosphate, lamivudine triphosphate and tenofovir diphosphate in human peripheral blood mononuclear cells, J.Mass Spectrom, vol.43, pp.224-233, 2008.

J. Rautio, J. E. Humphreys, L. O. Webster, A. Balakrishnan, J. P. Keogh et al., IN VITRO P-GLYCOPROTEIN INHIBITION ASSAYS FOR ASSESSMENT OF CLINICAL DRUG INTERACTION POTENTIAL OF NEW DRUG CANDIDATES: A RECOMMENDATION FOR PROBE SUBSTRATES, Drug Metabolism and Disposition, vol.34, issue.5, pp.786-792, 2006.
DOI : 10.1124/dmd.105.008615

M. D. Vela, L. M. Fuller, E. J. Wieman, G. R. Eisenberg, and . Rhodes, Mechanism of active renal tubular efflux of tenofovir, Antimicrob.Agents Chemother, vol.50, pp.3297-3304, 2006.

K. Grube, H. K. Kock, and . Kroemer, Cellular export of drugs and signaling molecules by the ATPbinding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5), Drug Metab Rev, vol.37, pp.253-278, 2005.

J. Haefeli and . Weiss, Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein, 2007.

J. Greenblatt, Differential modulation of Pglycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture, 2002.

T. W. Synold, I. Dussault, and B. M. Forman, The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux, Nature Medicine, vol.7, issue.5, pp.584-590, 2001.
DOI : 10.1038/87912

B. Banide, R. Lacour, and . Farinotti, Effect of interleukin-2 on intestinal P-glycoprotein expression and functionality in mice, J Pharmacol.Exp.Ther, vol.302, pp.742-750, 2002.

J. Greenblatt, Lopinavir: acute exposure inhibits Pglycoprotein ; extended exposure induces P-glycoprotein, AIDS, vol.17, pp.1092-1094, 2003.

J. Weiss, D. Theile, N. Ketabi-kiyanvash, H. Lindenmaier, and W. E. Haefeli, Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors, Drug Metabolism and Disposition, vol.35, issue.3, pp.340-344, 2007.
DOI : 10.1124/dmd.106.012765

W. E. Storch and . Haefeli, Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors, Eur.J.Pharmacol, vol.579, pp.104-109, 2008.

C. E. Hatse, J. De, P. Balzarini, and . Borst, Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs, Proc.Natl.Acad.Sci.U.S A, vol.97, pp.7476-7481, 2000.

R. 1. Eisenblatter, T. Huwel, S. Galla, and H. , Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood???brain barrier, Brain Research, vol.971, issue.2, pp.221-231, 2003.
DOI : 10.1016/S0006-8993(03)02401-6

S. Lipton and H. Gendelman, Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome, N Engl J Med, vol.332, issue.14, pp.934-940, 1995.

E. Choo, B. Leake, and C. Wandel, Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1

C. Cordon-cardo, O. Brien, J. Casals, and D. , Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites., Proceedings of the National Academy of Sciences, vol.86, issue.2, pp.695-698, 1989.
DOI : 10.1073/pnas.86.2.695

M. Huisman, J. Smit, and H. Wiltshire, Pglycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir, Mol Pharmacol, vol.59, issue.4, pp.806-813, 2001.

R. Kim, M. Fromm, and C. Wandel, The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors., Journal of Clinical Investigation, vol.101, issue.2, pp.289-294, 1998.
DOI : 10.1172/JCI1269

P. Black and A. Htlv-iii, HTLV-III, AIDS, and the Brain, New England Journal of Medicine, vol.313, issue.24, pp.1538-1540, 1985.
DOI : 10.1056/NEJM198512123132409

T. Litman, T. Druley, W. Stein, and S. Bates, From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance, Cellular and Molecular Life Sciences, vol.58, issue.7, pp.931-959, 2001.
DOI : 10.1007/PL00000912

A. Seelig, X. Blatter, and F. Wohnsland, Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison, Int. Journal of Clinical Pharmacology and Therapeutics, vol.38, issue.03, pp.111-121, 2000.
DOI : 10.5414/CPP38111

M. Perloff, V. Moltke, L. Marchand, J. Greenblatt, and D. , Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line, Journal of Pharmaceutical Sciences, vol.90, issue.11, pp.1829-1837, 2001.
DOI : 10.1002/jps.1133

D. Vishnuvardhan, L. Moltke, C. Richert, and D. Greenblatt, Lopinavir, AIDS, vol.17, issue.7, pp.1092-1094, 2003.
DOI : 10.1097/00002030-200305020-00023

M. Perloff, V. Moltke, L. Fahey, J. Greenblatt, and D. , Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cells, Journal of Pharmacy and Pharmacology, vol.306, issue.Suppl. 2, pp.947-953, 2007.
DOI : 10.1211/jpp.59.7.0006

B. Chandler, L. Almond, and J. Ford, The Effects of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors on P-Glycoprotein Expression in Peripheral Blood Mononuclear Cells In Vitro, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.33, issue.5, pp.551-556, 2003.
DOI : 10.1097/00126334-200308150-00001

J. Ford, E. Meaden, and P. Hoggard, Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression, Journal of Antimicrobial Chemotherapy, vol.52, issue.3, pp.354-358, 2003.
DOI : 10.1093/jac/dkg381

M. Huisman, J. Smit, and K. Crommentuyn, Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs, AIDS, vol.16, issue.17, pp.2295-2301, 2002.
DOI : 10.1097/00002030-200211220-00009

A. Gupta, Y. Zhang, J. Unadkat, and Q. Mao, HIV Protease Inhibitors Are Inhibitors but Not Substrates of the Human Breast Cancer Resistance Protein (BCRP/ABCG2), Journal of Pharmacology and Experimental Therapeutics, vol.310, issue.1, pp.334-341, 2004.
DOI : 10.1124/jpet.104.065342

J. Weiss, J. Rose, and C. Storch, Modulation of human BCRP (ABCG2) activity by anti-HIV drugs, Journal of Antimicrobial Chemotherapy, vol.59, issue.2, pp.238-245, 2007.
DOI : 10.1093/jac/dkl474

E. Perloff, S. Duan, P. Skolnik, D. Greenblatt, V. Moltke et al., ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO, Drug Metabolism and Disposition, vol.33, issue.6, pp.764-770, 2005.
DOI : 10.1124/dmd.104.002931

L. Chinn, J. Gow, M. Tse, S. Becker, and D. Kroetz, Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein, Journal of Antimicrobial Chemotherapy, vol.60, issue.1, pp.61-67, 2007.
DOI : 10.1093/jac/dkm135

M. Lucia, C. Golotta, and S. Rutella, Atazanavir inhibits P-glycoprotein and multidrug resistanceassociated protein efflux activity, J Acquir Immune Defic Syndr, vol.39, issue.5, pp.635-637, 2005.

V. Josserand, H. Pelerin, and B. Bruin, Evaluation of Drug Penetration into the Brain: A Double Study by in Vivo Imaging with Positron Emission Tomography and Using an in Vitro Model of the Human Blood-Brain Barrier, Journal of Pharmacology and Experimental Therapeutics, vol.316, issue.1, pp.79-86, 2006.
DOI : 10.1124/jpet.105.089102

I. Megard, A. Garrigues, and S. Orlowski, A co-culture-based model of human blood???brain barrier: application to active transport of indinavir and in vivo???in vitro correlation, Brain Research, vol.927, issue.2, pp.153-167, 2002.
DOI : 10.1016/S0006-8993(01)03337-6

E. Meaden, P. Hoggard, S. Khoo, and D. Back, Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo, Journal of Immunological Methods, vol.262, issue.1-2, pp.159-165, 2002.
DOI : 10.1016/S0022-1759(02)00020-0

C. Fernetti, L. Pascolo, and E. Podda, Preparation of an Antibody Recognizing both Human and Rodent MRP1, Biochemical and Biophysical Research Communications, vol.288, issue.4, pp.1064-1068, 2001.
DOI : 10.1006/bbrc.2001.5885

C. Storch, D. Theile, H. Lindenmaier, W. Haefeli, and J. Weiss, Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein, Biochemical Pharmacology, vol.73, issue.10
DOI : 10.1016/j.bcp.2007.01.027

O. Legrand, G. Simonin, J. Perrot, R. Zittoun, and J. Marie, Pgp and MRP activities using calcein- AM are prognostic factors in adult acute myeloid leukemia patients, Blood, vol.91, issue.12, pp.4480-4488, 1998.

V. Gekeler, W. Ise, K. Sanders, W. Ulrich, and J. Beck, The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance, Biochemical and Biophysical Research Communications, vol.208, issue.1, pp.345-352, 1995.
DOI : 10.1006/bbrc.1995.1344

DOI : 10.1124/dmd.105.008615

J. Allen, L. Van, and J. Lakhai, Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C, Mol Cancer Ther, vol.1, issue.6, pp.417-425, 2002.

V. Sadanand, J. Kankesan, and A. Yusuf, Effect of PSC 833, a potent inhibitor of P-glycoprotein, on the growth of astrocytoma cells in vitro, Cancer Letters, vol.198, issue.1, pp.21-27, 2003.
DOI : 10.1016/S0304-3835(03)00270-2

C. Roucairol, S. Azoulay, and M. Nevers, Quantitative Immunoassay To Measure Plasma and Intracellular Atazanavir Levels: Analysis of Drug Accumulation in Cultured T Cells, Antimicrobial Agents and Chemotherapy, vol.51, issue.2, pp.405-411, 2007.
DOI : 10.1128/AAC.00730-06

E. Solon, S. Balani, and G. Luo, Interaction of Ritonavir on Tissue Distribution of a [14C]L-Valinamide, a Potent Human Immunodeficiency Virus-1 Protease Inhibitor, in Rats Using Quantitative Whole-Body Autoradiography, Drug Metabolism and Disposition, vol.30, issue.11, pp.1164-1169, 2002.
DOI : 10.1124/dmd.30.11.1164

C. Anthonypillai, J. Gibbs, and S. Thomas, The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses, Cerebrospinal Fluid Research, vol.3, issue.1, p.1, 2006.
DOI : 10.1186/1743-8454-3-1

D. Goldsmith, C. Perry, and . Atazanavir, Atazanavir, Drugs, vol.17, issue.9, pp.1679-1693, 2003.
DOI : 10.2165/00003495-200363160-00003

A. Taburet, C. Piketty, and C. Chazallon, Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients, Antimicrobial Agents and Chemotherapy, vol.48, issue.6, pp.2091-2096, 2004.
DOI : 10.1128/AAC.48.6.2091-2096.2004

B. Bauer, A. Hartz, G. Fricker, and D. Miller, Pregnane X receptor up-regulation of Pglycoprotein expression and transport function at the blood-brain barrier, Mol Pharmacol, vol.66, issue.3, pp.413-419, 2004.

G. Siest, E. Jeannesson, and J. Marteau, Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects, Drug Metabolism and Disposition, vol.36, issue.1, 2007.
DOI : 10.1124/dmd.107.017228

W. Cavert, D. Notermans, K. Staskus, S. Wietgrefe, M. Zupancic et al., Haase AT Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection Science, pp.960-964, 1997.

B. Chandler, L. Almond, J. Ford, A. Owen, P. Hoggard et al., The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro J Acquir Immune Defic Syndr, pp.551-557, 2003.

G. Chang and C. Roth, Structure of MsbA from E. coli: A Homolog of the Multidrug Resistance ATP Binding Cassette (ABC) Transporters, Science, vol.293, issue.5536, pp.1793-800, 2001.
DOI : 10.1126/science.293.5536.1793

M. Chang, V. Sood, G. Wilson, D. Kloosterman, P. Sanders et al., Branstetter DG Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice Drug Metab Dispos, pp.828-867, 1997.

P. Chaudhary and I. Roninson, Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells, Cell, vol.66, issue.1, pp.85-94, 1991.
DOI : 10.1016/0092-8674(91)90141-K

R. Chen and J. Kilby, Enfuvirtide, Expert Opinion on Investigational Drugs, vol.72, issue.12, pp.1837-1880, 2002.
DOI : 10.1128/AAC.46.6.1896-1905.2002

C. Chen, M. Vazquez-padua, and Y. Cheng, Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity Mol Pharmacol, pp.625-633, 1991.

Y. Chiu, V. Soros, J. Kreisberg, K. Stopak, W. Yonemoto et al., Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells Nature, pp.108-122, 2005.

S. Choudhuri, C. Klaassen, and . Structure, Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters, International Journal of Toxicology, vol.876, issue.4, pp.231-59, 2006.
DOI : 10.1080/10915810600746023

T. Chun, L. Carruth, D. Finzi, X. Shen, J. Digiuseppe et al., Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection Nature, pp.183-191, 1997.

T. Chun, D. Engel, M. Berrey, T. Shea, and L. Corey, Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection, Proceedings of the National Academy of Sciences, vol.95, issue.15, pp.8869-73, 1998.
DOI : 10.1073/pnas.95.15.8869

T. Chun and A. Fauci, Latent reservoirs of HIV: Obstacles to the eradication of virus, Proceedings of the National Academy of Sciences, vol.96, issue.20, pp.10958-61, 1999.
DOI : 10.1073/pnas.96.20.10958

M. Flens, M. Izquierdo, G. Scheffer, J. Fritz, C. Meijer et al., Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies Cancer Res, pp.4557-63, 1994.

M. Flens, G. Zaman, P. Van-der-valk, M. Izquierdo, A. Schroeijers et al., Scheper RJ Tissue distribution of the multidrug resistance protein, Am J Pathol, vol.148, issue.4, pp.1237-1284, 1996.

A. Fojo, R. Lebo, N. Shimizu, J. Chin, I. Roninson et al., Localization of multidrug resistance-associated DNA sequences to human chromosome 7, Somatic Cell and Molecular Genetics, vol.40, issue.4
DOI : 10.1007/BF01570737

A. Fojo, K. Ueda, D. Slamon, D. Poplack, and M. Gottesman, Expression of a multidrug-resistance gene in human tumors and tissues., Proceedings of the National Academy of Sciences, vol.84, issue.1, pp.265-274, 1987.
DOI : 10.1073/pnas.84.1.265

T. Folks, J. Justement, A. Kinter, and C. Dinarello, Fauci AS Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line Science, pp.800-802, 1987.

T. Folks, S. Kessler, J. Orenstein, J. Justement, and E. Jaffe, Fauci AS Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow Science, pp.919-941, 1988.

J. Ford, M. Boffito, D. Maitland, A. Hill, D. Back et al., Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients, Journal of Antimicrobial Chemotherapy, vol.58, issue.5, pp.1009-1025, 2006.
DOI : 10.1093/jac/dkl379

J. Ford, E. Meaden, P. Hoggard, M. Dalton, P. Newton et al., Back DJ Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression J Antimicrob Chemother, pp.354-362, 2003.

L. Frick, S. John, L. Taylor, L. Painter, G. Furman et al., oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2- (hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus Antimicrob Agents Chemother, pp.2285-92, 1993.

Y. Fukushima, Y. Oshika, T. Tokunaga, H. Hatanaka, M. Tomisawa et al., Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer Eur J Cancer, pp.935-943, 1999.

M. Furuse, T. Hirase, M. Itoh, A. Nagafuchi, S. Yonemura et al., Occludin: a novel integral membrane protein localizing at tight junctions, The Journal of Cell Biology, vol.123, issue.6, pp.1777-88, 1993.
DOI : 10.1083/jcb.123.6.1777

C. Lee, M. Ramachandra, K. Jeang, M. Martin, and I. Pastan, Gottesman MM Effect of ABC transporters on HIV-1 infection: inhibition of virus production by the MDR1 transporter, FASEB J, vol.14, issue.3, pp.516-538, 2000.

G. Lee, L. Schlichter, and M. Bendayan, Bendayan R Functional expression of P-glycoprotein in rat brain microglia, J Pharmacol Exp Ther, vol.299, issue.1, pp.204-216, 2001.

O. Legrand, G. Simonin, J. Perrot, R. Zittoun, and J. Marie, Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients Blood, Jun, vol.1591, issue.12, pp.4480-4488, 1998.

E. Leslie, R. Deeley, and S. Cole, Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense, Toxicology and Applied Pharmacology, vol.204, issue.3, pp.216-253, 2005.
DOI : 10.1016/j.taap.2004.10.012

S. Letendre, G. Van-den-brande, A. Hermes, S. Woods, J. Durelle et al., Ellis RJ; the HIV Neurobehavioral Research Center Group Lopinavir with Ritonavir Reduces the HIV RNA Level in Cerebrospinal Fluid Clin Infect Dis, 2007.

T. Licht, H. Fiebig, K. Bross, F. Herrmann, D. Berger et al., Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro, Int J Cancer, issue.4, pp.49630-49637, 1991.

K. Miyake, L. Mickley, T. Litman, Z. Zhan, R. Robey et al., Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes Cancer Res, pp.8-13, 1999.

H. Mo, N. Parkin, K. Stewart, L. Lu, T. Dekhtyar et al., Molla A Identification and structural characterization of I84C and I84A mutations that are associated with high-level resistance to human immunodeficiency virus protease inhibitors and impair viral replication Antimicrob Agents Chemother, Feb, vol.51, issue.2, pp.732-737, 2007.

J. Molina, G. Peytavin, S. Perusat, C. Lascoux-combes, D. Sereni et al., Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIVinfected adults

K. Moore, R. Raasch, K. Brouwer, K. Opheim, S. Cheeseman et al., van der Horst CM Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease, AIDS Clinical Trials Group, vol.062

K. Morita, H. Sasaki, M. Furuse, and S. Tsukita, Endothelial Claudin, The Journal of Cell Biology, vol.107, issue.1, pp.185-94, 1999.
DOI : 10.1083/jcb.120.2.477

M. Moura, M. Senna, D. Madureira, L. Fonseca, and R. Mesquita, Oral adverse effects due to the use of Nevirapine J Contemp Dent Pract, pp.84-90, 2008.

M. Mouroux, J. Izopet, D. Descamps, C. Delaugerre, A. Yvon-groussin et al., Brun-Vezinet F, Calvez V Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T, Pathol Biol, vol.48, issue.5, pp.508-520, 2000.

G. Moyle and D. Back, Principles and practice of HIV-protease inhibitor pharmacoenhancement HIV Med, pp.105-118, 2001.

M. Müller, C. Meijer, G. Zaman, P. Borst, R. Scheper et al., Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport., Proceedings of the National Academy of Sciences, vol.91, issue.26, pp.13033-13040, 1994.
DOI : 10.1073/pnas.91.26.13033

M. Muredda, K. Nunoya, R. Burtch-wright, E. Kurz, and S. Cole, Deeley RG Cloning and Characterization of the Murine and Rat mrp1 Promoter Regions Mol Pharmacol, pp.1259-69, 2003.

L. Musey, J. Hughes, T. Schacker, T. Shea, and L. Corey, Cytotoxic-T-Cell Responses, Viral Load, and Disease Progression in Early Human Immunodeficiency Virus Type 1 Infection, New England Journal of Medicine, vol.337, issue.18, pp.1267-74, 1997.
DOI : 10.1056/NEJM199710303371803

P. Ronaldson, G. Lee, S. Dallas, and R. Bendayan, Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines Pharm Res, pp.811-819, 2004.

I. Roninson, J. Chin, K. Choi, P. Gros, D. Housman et al., Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells., Proceedings of the National Academy of Sciences, vol.83, issue.12, pp.4538-4580, 1986.
DOI : 10.1073/pnas.83.12.4538

M. Rosenberg, R. Callaghan, and R. Ford, Higgins CF Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis, J Biol Chem, vol.272, issue.16, pp.10685-94, 1997.

J. Rosenfeld, R. Vargas, . Jr, W. Xie, and R. Evans, Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor Mol Endocrinol, pp.1268-82, 2003.

S. Rostad, S. Sumi, C. Shaw, K. Olson, and J. Mcdougall, Human Immunodeficiency Virus (HIV) Infection in Brains with AIDS-Related Leukoencephalopathy, AIDS Research and Human Retroviruses, vol.3, issue.4, pp.363-73, 1987.
DOI : 10.1089/aid.1987.3.363

C. Roucairol, S. Azoulay, M. Nevers, C. Créminon, T. Lavrut et al., Quantitative immunoassay to measure plasma and intracellular atazanavir levels: analysis of drug accumulation in cultured T cells Antimicrob Agents Chemother, Feb, vol.51, issue.2, pp.405-416, 2007.

F. Roux, R. Mokni, C. Hughes, P. Clouet, and J. Lefauconnier, Lipid Synthesis by Rat Brain Microvessel Endothelial Cells in Tissue Culture, Journal of Neuropathology and Experimental Neurology, vol.48, issue.4, pp.437-484, 1989.
DOI : 10.1097/00005072-198907000-00005

M. Saag, P. Cahn, F. Raffi, M. Wolff, D. Pearce et al., Rousseau F; FTC-301A Study Team Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial JAMA, pp.180-189, 2004.

V. Sadanand, J. Kankesan, A. Yusuf, C. Stewart, J. Rutka et al., Effect of PSC 833, a potent inhibitor of P-glycoprotein, on the growth of astrocytoma cells in vitro Cancer Lett, pp.21-28, 2003.

S. Saito, A. Iida, A. Sekine, Y. Miura, C. Ogawa et al., Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC

E. Solon, S. Balani, G. Luo, T. Yang, P. Haines et al., Lee FW Interaction of ritonavir on tissue distribution of a [(14)c]L-valinamide, a potent human immunodeficiency virus- 1 protease inhibitor, in rats using quantitative whole-body autoradiography Drug Metab Dispos, pp.1164-1173, 2002.

R. Speck, X. Yu, J. Hildreth, and C. Flexner, Differential effects of p-glycoprotein and multidrug resistance protein-1 on productive human immunodeficiency virus infection J Infect Dis, pp.332-372, 2002.

R. Srinivas, D. Middlemas, and P. Flynn, Fridland A Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters Antimicrob Agents Chemother, pp.3157-62, 1998.

J. Staddon, K. Herrenknecht, C. Schulze, and C. Smales, Rubin LL Signal transduction at the blood-brain barrier Biochem Soc Trans, pp.475-484, 1995.

B. Starcich, B. Hahn, G. Shaw, P. Mcneely, S. Modrow et al., Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS, Cell, vol.45, issue.5, pp.45637-45685, 1986.
DOI : 10.1016/0092-8674(86)90778-6

N. Strazielle and . Ghersi-egea, JF Factors affecting delivery of antiviral drugs to the brain Rev Med Virol, pp.105-138, 2005.

M. Steinberg and P. Mcnutt, Cadherins and their connections: adhesion junctions have broader functions, Current Opinion in Cell Biology, vol.11, issue.5, pp.554-60, 1999.
DOI : 10.1016/S0955-0674(99)00027-7

M. Stevenson, T. Stanwick, and M. Dempsey, Lamonica CA HIV-1 replication is controlled at the level of T cell activation and proviral integration EMBO J, pp.1551-60, 1990.

N. Stone, S. Dunaway, C. Flexner, C. Tierney, G. Calandra et al., Hendrix CW Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects Antimicrob Agents Chemother, pp.2351-2359, 2007.

C. Storch, D. Theile, H. Lindenmaier, W. Haefeli, and J. Weiss, Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein Biochem Pharmacol, pp.1573-81, 2007.

E. Störmer, L. Von-moltke, and M. Perloff, Greenblatt DJ Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture Pharm Res, pp.1038-1083, 2002.

W. Sugiura, Z. Matsuda, Y. Yokomaku, K. Hertogs, B. Larder et al., Interference between D30N and L90M in Selection and Development of Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1, Antimicrobial Agents and Chemotherapy, vol.46, issue.3
DOI : 10.1128/AAC.46.3.708-715.2002

H. Van-veen, A. Margolles, M. Müller, and C. Higgins, Konings WN The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating twosite (two-cylinder engine) mechanism EMBO J, pp.2503-2517, 2000.

C. Veau, L. Faivre, S. Tardivel, M. Soursac, H. Banide et al., Effect of Interleukin-2 on Intestinal P-glycoprotein Expression and Functionality in Mice, Journal of Pharmacology and Experimental Therapeutics, vol.302, issue.2, pp.742-50, 2002.
DOI : 10.1124/jpet.302.2.742

A. Veldkamp, G. Weverling, J. Lange, J. Montaner, P. Reiss et al., Hoetelmans RM High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals AIDS, pp.1089-95, 2001.

S. Vella, Clinical experience with saquinavir AIDS, pp.21-25, 1995.

J. Vingerhoets, H. Azijn, E. Fransen, D. Baere, I. Smeulders et al., TMC125 Displays a High Genetic Barrier to the Development of Resistance: Evidence from In Vitro Selection Experiments, Journal of Virology, vol.79, issue.20, pp.12773-82, 2005.
DOI : 10.1128/JVI.79.20.12773-12782.2005

D. Vishnuvardhan, L. Moltke, C. Richert, D. Greenblatt, and . Lopinavir, acute exposure inhibits P-glycoprotein; extended exposure induces P-glycoprotein AIDS, pp.1092-1096, 2003.

S. Wain-hobson, P. Sonigo, O. Danos, and S. Cole, Nucleotide sequence of the AIDS virus, LAV, Cell, vol.40, issue.1, pp.9-17, 1985.
DOI : 10.1016/0092-8674(85)90303-4

Q. Wang and W. Beck, Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53 Cancer Res, pp.5762-5771, 1998.

J. Ward, O. Leary, T. Baskin, G. Benveniste, R. Harris et al., Rhodes RH Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections, Am J Pathol, vol.127, issue.2, pp.199-205, 1987.

C. Washington, G. Duran, M. Man, and B. Sikic, Blaschke TF Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells J Acquir Immune Defic Syndr Hum Retrovirol, pp.203-212, 1998.

B. Watkins, H. Dorn, W. Kelly, R. Armstrong, B. Potts et al., Dubois-Dalcq M Specific tropism of HIV-1 for microglial cells in primary human brain cultures Science, pp.549-53, 1990.

X. Wei, J. Decker, H. Liu, Z. Zhang, R. Arani et al., Kappes JC Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy Antimicrob Agents Chemother, pp.1896-905, 2002.

J. Weiss, S. Dormann, M. Martin-facklam, and C. Kerpen, Inhibition of P-Glycoprotein by Newer Antidepressants, Journal of Pharmacology and Experimental Therapeutics, vol.305, issue.1, pp.197-204, 2003.
DOI : 10.1124/jpet.102.046532

J. Weiss, J. Rose, C. Storch, N. Ketabi-kiyanvash, A. Sauer et al., Efferth T (a) Modulation of human BCRP (ABCG2) activity by anti-HIV drugs J Antimicrob Chemother, Feb, vol.59, issue.2, pp.238-283, 2007.

J. Weiss, D. Theile, N. Ketabi-kiyanvash, H. Lindenmaier, and W. Haefeli, Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors Drug Metab Dispos, pp.340-344, 2007.

J. Weiss, N. Weis, N. Ketabi-kiyanvash, and C. Storch, Haefeli WE Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors, Eur J Pharmacol, vol.579, pp.1-3104, 2008.

B. Weniger, Y. Takebe, and C. Ou, Yamazaki S The molecular epidemiology of HIV in Asia AIDS, pp.13-28, 1994.

J. Whitcomb, N. Parkin, C. Chappey, and N. Hellmann, Petropoulos CJ Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates J Infect Dis, pp.992-1000, 2003.

K. White and N. Margot, Molecular Mechanisms of Resistance to Human Immunodeficiency Virus Type 1 with Reverse Transcriptase Mutations K65R and K65R+M184V and Their Effects on Enzyme Function and Viral Replication Capacity, Antimicrobial Agents and Chemotherapy, vol.46, issue.11, pp.3437-3446, 2002.
DOI : 10.1128/AAC.46.11.3437-3446.2002

K. Wiegers, G. Rutter, H. Kottler, U. Tessmer, H. Hohenberg et al., Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites, J Virol, issue.4, pp.722846-54, 1998.

P. Wielinga, G. Reid, E. Challa, I. Van-der-heijden, L. Van-deemter et al., Borst P Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells Mol Pharmacol, pp.1321-1352, 2002.

J. Wijnholds, C. Mol, L. Van-deemter, M. De-haas, G. Scheffer et al., Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs, Proceedings of the National Academy of Sciences, vol.97, issue.13, pp.7476-81, 2000.
DOI : 10.1073/pnas.120159197

C. Wiley, C. Achim, C. Christopherson, Y. Kidane, S. Kwok et al., Soontornniyomkij V HIV mediates a productive infection of the brain AIDS, pp.2055-2064, 1999.

C. Wiley and J. Nelson, Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis, Am J Pathol, vol.133, issue.1, pp.73-81, 1988.

C. Wiley, R. Schrier, J. Nelson, and P. Lampert, Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients., Proceedings of the National Academy of Sciences, vol.83, issue.18, pp.7089-93, 1986.
DOI : 10.1073/pnas.83.18.7089

R. Willey, R. Rutledge, S. Dias, T. Folks, T. Theodore et al., Martin MA Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus, Proc Natl Acad Sci U S A, issue.14, pp.835038-835080, 1986.

S. Williams and W. Greene, Regulation of HIV-1 latency by T-cell activation Cytokine, pp.63-74, 2007.

G. Williams, A. Liu, and G. Knipp, Sinko PJ Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2) Antimicrob Agents Chemother, pp.3456-62, 2002.

G. Williams and P. Sinko, Oral absorption of the HIV protease inhibitors: a current update Adv Drug Deliv Rev, Oct, vol.1839, pp.1-3211, 1999.

J. Winston, L. Bruggeman, M. Ross, J. Jacobson, L. Ross et al., Nephropathy and Establishment of a Renal Reservoir of HIV Type 1 during Primary Infection, New England Journal of Medicine, vol.344, issue.26, pp.1979-84, 2001.
DOI : 10.1056/NEJM200106283442604

M. Witvrouw, C. Pannecouque, W. Switzer, T. Folks, D. Clercq et al., Heneine W Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis Antivir Ther, Feb, vol.9, issue.1, pp.57-65, 2004.

H. Wolburg and A. Lippoldt, Tight junctions of the blood???brain barrier, Vascular Pharmacology, vol.38, issue.6, pp.323-360, 2002.
DOI : 10.1016/S1537-1891(02)00200-8

S. Wright, A. Boag, G. Valdimarsson, D. Hipfner, B. Campling et al., Deeley RG Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung Clin Cancer Res, pp.2279-89, 1998.

D. Wu, J. Clement, and W. Pardridge, Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat Brain Res, pp.313-319, 1998.

C. Wyen, U. Fuhr, D. Frank, R. Aarnoutse, T. Klaassen et al., Jetter A Effect of an Antiretroviral Regimen Containing Ritonavir Boosted Lopinavir on Intestinal and Hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected Patients Clin Pharmacol Ther, 2008.

Z. Yang, R. Brundage, R. Barbhaiya, and R. Sawchuk, Microdialysis studies of the distribution of stavudine into the central nervous system in the freely-moving rat Pharm Res, pp.865-72, 1997.